Zhang Lifang, Cao Jessica, Yang Haiqiang, Pham Phillip, Khan Umer, Brown Breanna, Wang Yanhong, Zieneldien Tarek, Cao Chuanhai
Department of Neurological Rehabilitation, The Affiliated Brain Hospital of Guangzhou Medical University, Guanzhou, China.
Department of Kinesiology, Wiess School of Natural Sciences, Rice University, Houston, TX, United States.
Front Nutr. 2022 Mar 15;9:850523. doi: 10.3389/fnut.2022.850523. eCollection 2022.
Alzheimer's disease (AD) is a multifactorial neurological disease with neurofibrillary tangles and neuritic plaques as histopathological markers. Due to this, although AD is the leading cause of dementia worldwide, clinical AD dementia cannot be certainly diagnosed until neuropathological post-mortem evaluation. Coffee has been reported to have neurologically protective factors, particularly against AD, but coffee brand and type have not been taken into consideration in previous studies. We examined the discrepancies among popular commercial and instant coffees in limiting the development and progression through Aβ1-40 and Aβ1-42 production, and hypothesized that coffee consumption, regardless of brand or type, is beneficial for stalling the progression and development of Aβ-related AD.
Coffee samples from four commercial coffee brands and four instant coffees were purchased or prepared following given instructions and filtered for the study. 5, 2.5, and 1.25% concentrations of each coffee were used to treat N2a/APPswe cell lines. MTT assay was used to assess cell viability for coffee concentrations, as well as pure caffeine concentrations. Sandwich ELISA assay was used to determine Aβ concentration for Aβ1-40 and Aβ1-42 peptides of coffee-treated cells.
Caffeine concentrations were significantly varied among all coffees (DC vs. MDC, PC, SB, NIN, MIN < 0.05). There was no correlation between caffeine concentration and cell toxicity among brands and types of coffee, with no toxicity at 0.5 mg/ml caffeine and lower. Most coffees were toxic to N2a/APPswe cells at 5% ( < 0.05), but not at 2.5%. Most coffees at a 2.5% concentration reduced Aβ1-40 and Aβ1-42 production, with comparable results between commercial and instant coffees.
All coffees tested have beneficial health effects for AD through lowering Aβ1-40 and Aβ1-42 production, with Dunkin' Donuts® medium roast coffee demonstrating the most consistent and optimal cell survival rates and Aβ concentration. On the other hand, Starbucks® coffee exhibited the highest cell toxicity rates among the tested coffees.
阿尔茨海默病(AD)是一种多因素神经疾病,以神经原纤维缠结和神经炎性斑块作为组织病理学标志物。正因如此,尽管AD是全球痴呆症的主要病因,但在进行神经病理学尸检评估之前,临床AD痴呆症无法得到确切诊断。据报道,咖啡具有神经保护因子,尤其是对AD具有保护作用,但先前的研究未考虑咖啡品牌和类型。我们研究了流行的商业咖啡和速溶咖啡在通过Aβ1-40和Aβ1-42生成来限制疾病发展和进展方面的差异,并假设饮用咖啡,无论品牌或类型,都有利于延缓与Aβ相关的AD的进展和发展。
按照给定说明购买或制备来自四个商业咖啡品牌和四种速溶咖啡的咖啡样品,并进行过滤用于研究。使用5%、2.5%和1.25%浓度的每种咖啡处理N2a/APPswe细胞系。MTT法用于评估咖啡浓度以及纯咖啡因浓度下的细胞活力。夹心ELISA法用于测定经咖啡处理的细胞中Aβ1-40和Aβ1-42肽的Aβ浓度。
所有咖啡中的咖啡因浓度差异显著(深度烘焙咖啡与中度深度烘焙咖啡、纯咖啡、浅度烘焙咖啡、雀巢咖啡、麦斯威尔咖啡相比,P<0.05)。咖啡品牌和类型中,咖啡因浓度与细胞毒性之间无相关性,咖啡因浓度在0.5mg/ml及以下时无毒性。大多数咖啡在5%浓度时对N2a/APPswe细胞有毒性(P<0.05),但在2.5%浓度时无毒性。大多数2.5%浓度的咖啡可降低Aβ1-40和Aβ1-42的生成,商业咖啡和速溶咖啡的结果相当。
所有测试咖啡通过降低Aβ1-40和Aβ1-42的生成对AD具有有益的健康影响,唐恩都乐®中度烘焙咖啡表现出最一致且最佳的细胞存活率和Aβ浓度。另一方面,星巴克®咖啡在测试咖啡中表现出最高的细胞毒性率。